Healthways Inc. has announced that it expects its pilot program to determine whether disease management lowers the cost of treating patients with chronic illnesses to meet specified performance targets. The move questions conclusions by Medicare that had caused Healthways stock to plunge.
Trending:
Healthways questions Medicare finding